With the ageing of the society, the incidence of neurological diseases like stroke, Parkinson and Complex Regional Pain syndrome will increase. The socio-economic impact of stroke is very high. Estimated annual costs of stroke in the Netherlands are 1.200 M Euro. For people over 65 years it is the second in ranking after dementia. Parkinson’s disease is also an age-related disorder affecting 120-180 in 100,000 individuals. Syndromes associated with chronification of pain account for about 30% of sick leave of employees, costing several billions of Euros. The incidence is expected to have increased by 45% in 2025.
Currently, therapeutic options for stroke, Parkinson’s disease and neuropathic pain syndromes are sparse, not evidence-based but based on general concepts. This results in unnecessary long-lasting disability and loss of autonomy. This is in sharp contrast to one of the most important insights of the last decades that the human brain is highly […]